An-ting Liou
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hidden asymptomatic breakthrough infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients.
Journal: Journal of biomedical science
Published: February 11, 2026
Novel Naturally Occurring Mutations of Enterovirus 71 Associated With Disease Severity.
Journal: Frontiers in microbiology
Published: September 26, 2020
A Polysaccharide Purified From Ganoderma lucidum Acts as a Potent Mucosal Adjuvant That Promotes Protective Immunity Against the Lethal Challenge With Enterovirus A71.
Journal: Frontiers in immunology
Published: May 13, 2020
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model.
Journal: Journal of biomedical science
Published: August 06, 2019
Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model.
Journal: Scientific reports
Published: March 18, 2019
Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy.
Journal: Viruses
Published: November 01, 2018
Curcumin Induces p53-Null Hepatoma Cell Line Hep3B Apoptosis through the AKT-PTEN-FOXO4 Pathway.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: February 25, 2017
A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71.
Journal: Scientific reports
Published: June 15, 2016
Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.
Journal: Journal of virology
Published: August 22, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026